Will Sanders, Veranova’s Global VP of Chemical Development Operations, recently spoke to Tim Wright at Contract Pharma to discuss the development and manufacture of complex APIs.
In this podcast, Will explores why APIs are becoming more technically demanding across areas such as oncology, highly potent compounds, ADC payloads, peptides, and other TIDES modalities. He also discusses how CDMOs are adapting through specialized chemistry, containment strategies, advanced purification, scalable peptide technologies, and greener process development.
Listen to the Podcast
